TP53 mitigates cisplatin resistance in non-small cell lung cancer by mediating the effects of resistant cell-derived exosome mir-424-5p
Article in Heliyon (February 2024)
The most recent citing publications are shown below. View all 14 publications that cite this research output on Dimensions.
Article in Heliyon (February 2024)
Article in Cell Communication and Signaling (January 2024)
Article in Biomedicines (December 2023)